UBS Group »

Zyversa Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Zyversa Therapeutics shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Zyversa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Zyversa Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zyversa Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $15k 20k 0.75
2023-12-31 $2.9k 3.3k 0.90

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon Call Option (AMZN)
Ubs Group SHS Call Option (UBS)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Meta Platforms Cl A Call Option (META)
Broadcom Call Option (AVGO)
Visa Com Cl A Call Option (V)
Alphabet Cap Stk Cl C Call Option (GOOG)
UnitedHealth Call Option (UNH)

View all positions for UBS Group

Top funds holding Zyversa Therapeutics

UBS Group

View all funds holding Zyversa Therapeutics